STOCK TITAN

Purple Innovation Reports Fourth Quarter and Full Year 2024 Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Purple Innovation (NASDAQ: PRPL) reported Q4 and full-year 2024 results, marking a return to positive Adjusted EBITDA after eight quarters. Q4 net revenue declined 11.6% to $129.0 million, while gross margin improved significantly to 42.9%. The company secured an additional $19.0 million in term loan financing.

Key Q4 metrics: Net loss improved to $(8.5) million from $(18.3) million year-over-year, Adjusted EBITDA reached $2.9 million compared to $(9.8) million last year. Full-year 2024 revenue was $487.9 million, down 4.4% from 2023, with net loss improving to $(97.9) million.

2025 Outlook: Purple expects revenue between $465-485 million and adjusted EBITDA of flat to positive $10 million. Q1 2025 guidance projects revenue of $102-107 million and adjusted EBITDA of $(6) to $(9) million. The company also announced a strategic review process to evaluate potential sale or merger options.

Purple Innovation (NASDAQ: PRPL) ha riportato i risultati del quarto trimestre e dell'intero anno 2024, segnando un ritorno a un EBITDA rettificato positivo dopo otto trimestri. Il fatturato netto del Q4 è diminuito dell'11,6% a 129,0 milioni di dollari, mentre il margine lordo è migliorato significativamente al 42,9%. L'azienda ha ottenuto ulteriori 19,0 milioni di dollari in finanziamenti tramite prestiti a termine.

Metriche chiave del Q4: La perdita netta è migliorata a $(8,5) milioni rispetto a $(18,3) milioni dell'anno precedente, l'EBITDA rettificato ha raggiunto 2,9 milioni di dollari rispetto a $(9,8) milioni dello scorso anno. Il fatturato dell'intero anno 2024 è stato di 487,9 milioni di dollari, in calo del 4,4% rispetto al 2023, con una perdita netta migliorata a $(97,9) milioni.

Prospettive per il 2025: Purple si aspetta un fatturato compreso tra 465 e 485 milioni di dollari e un EBITDA rettificato stabile o positivo di 10 milioni di dollari. Le previsioni per il Q1 2025 indicano un fatturato di 102-107 milioni di dollari e un EBITDA rettificato di $(6) a $(9) milioni. L'azienda ha anche annunciato un processo di revisione strategica per valutare potenziali opzioni di vendita o fusione.

Purple Innovation (NASDAQ: PRPL) reportó los resultados del cuarto trimestre y del año completo 2024, marcando un regreso a un EBITDA ajustado positivo después de ocho trimestres. Los ingresos netos del Q4 cayeron un 11.6% a 129.0 millones de dólares, mientras que el margen bruto mejoró significativamente al 42.9%. La compañía aseguró 19.0 millones de dólares adicionales en financiamiento de préstamo a plazo.

Métricas clave del Q4: La pérdida neta mejoró a $(8.5) millones desde $(18.3) millones año tras año, el EBITDA ajustado alcanzó 2.9 millones de dólares en comparación con $(9.8) millones del año pasado. Los ingresos del año completo 2024 fueron de 487.9 millones de dólares, una disminución del 4.4% respecto a 2023, con una pérdida neta mejorada a $(97.9) millones.

Perspectivas para 2025: Purple espera ingresos entre 465 y 485 millones de dólares y un EBITDA ajustado plano o positivo de 10 millones de dólares. La guía para el Q1 2025 proyecta ingresos de 102-107 millones de dólares y un EBITDA ajustado de $(6) a $(9) millones. La compañía también anunció un proceso de revisión estratégica para evaluar opciones de venta o fusión potenciales.

퍼플 이노베이션 (NASDAQ: PRPL)은 2024년 4분기 및 연간 실적을 발표하며 8분기 만에 긍정적인 조정 EBITDA로 돌아섰습니다. 4분기 순수익은 11.6% 감소하여 1억 2900만 달러에 달했으며, 총 마진은 42.9%로 크게 개선되었습니다. 회사는 추가로 1900만 달러의 기한 대출 자금을 확보했습니다.

4분기 주요 지표: 순손실은 전년 대비 $(8.5) 백만에서 $(18.3) 백만으로 개선되었으며, 조정 EBITDA는 작년 $(9.8) 백만에 비해 290만 달러에 도달했습니다. 2024년 전체 수익은 4억 8790만 달러로 2023년 대비 4.4% 감소했으며, 순손실은 $(97.9) 백만으로 개선되었습니다.

2025년 전망: 퍼플은 4억 6500만 달러에서 4억 8500만 달러 사이의 수익과 1000만 달러의 평탄하거나 긍정적인 조정 EBITDA를 예상하고 있습니다. 2025년 1분기 가이드는 1억 200만 달러에서 1억 700만 달러의 수익과 $(6)에서 $(9) 백만의 조정 EBITDA를 예상하고 있습니다. 회사는 또한 잠재적인 매각 또는 합병 옵션을 평가하기 위한 전략적 검토 프로세스를 발표했습니다.

Purple Innovation (NASDAQ: PRPL) a publié les résultats du quatrième trimestre et de l'année 2024, marquant un retour à un EBITDA ajusté positif après huit trimestres. Le chiffre d'affaires net du Q4 a diminué de 11,6 % pour atteindre 129,0 millions de dollars, tandis que la marge brute s'est considérablement améliorée à 42,9 %. L'entreprise a sécurisé 19,0 millions de dollars supplémentaires en financement par prêt à terme.

Métriques clés du Q4 : La perte nette s'est améliorée à $(8,5) millions contre $(18,3) millions d'une année sur l'autre, l'EBITDA ajusté a atteint 2,9 millions de dollars par rapport à $(9,8) millions l'année dernière. Le chiffre d'affaires de l'année 2024 s'est élevé à 487,9 millions de dollars, en baisse de 4,4 % par rapport à 2023, avec une perte nette améliorée à $(97,9) millions.

Perspectives pour 2025 : Purple prévoit un chiffre d'affaires compris entre 465 et 485 millions de dollars et un EBITDA ajusté stable ou positif de 10 millions de dollars. Les prévisions pour le Q1 2025 projettent un chiffre d'affaires de 102 à 107 millions de dollars et un EBITDA ajusté de $(6) à $(9) millions. L'entreprise a également annoncé un processus de révision stratégique pour évaluer les options potentielles de vente ou de fusion.

Purple Innovation (NASDAQ: PRPL) hat die Ergebnisse des vierten Quartals und des gesamten Jahres 2024 bekannt gegeben und markiert damit die Rückkehr zu einem positiven bereinigten EBITDA nach acht Quartalen. Der Nettoumsatz im Q4 ging um 11,6% auf 129,0 Millionen Dollar zurück, während die Bruttomarge erheblich auf 42,9% anstieg. Das Unternehmen sicherte sich zusätzlich 19,0 Millionen Dollar an Darlehensfinanzierung.

Wichtige Kennzahlen für das Q4: Der Nettoverlust verbesserte sich von $(18,3) Millionen auf $(8,5) Millionen im Jahresvergleich, das bereinigte EBITDA erreichte 2,9 Millionen Dollar im Vergleich zu $(9,8) Millionen im vergangenen Jahr. Der Umsatz für das gesamte Jahr 2024 betrug 487,9 Millionen Dollar, ein Rückgang um 4,4% im Vergleich zu 2023, wobei sich der Nettoverlust auf $(97,9) Millionen verbesserte.

Ausblick 2025: Purple erwartet einen Umsatz zwischen 465 und 485 Millionen Dollar und ein bereinigtes EBITDA von stabilen oder positiven 10 Millionen Dollar. Die Prognose für das erste Quartal 2025 sieht einen Umsatz von 102-107 Millionen Dollar und ein bereinigtes EBITDA von $(6) bis $(9) Millionen vor. Das Unternehmen kündigte außerdem einen strategischen Überprüfungsprozess an, um potenzielle Verkaufs- oder Fusionsoptionen zu bewerten.

Positive
  • First positive Adjusted EBITDA ($2.9M) in eight quarters
  • Q4 gross margin improved significantly to 42.9% (+970 bps)
  • Secured additional $19M term loan financing
  • Net loss improved from $(120.8M) to $(97.9M) year-over-year
  • 15% reduction in inventory levels
Negative
  • Q4 revenue declined 11.6% to $129M
  • Full-year revenue decreased 4.4% to $487.9M
  • DTC revenue down 4.4% and wholesale revenue down 4.5%
  • Full-year Adjusted EBITDA still negative at $(20.8M)
  • Q1 2025 guidance projects continued losses ($(6M) to $(9M) EBITDA)

Insights

Purple Innovation's Q4 results signal meaningful progress toward financial stability despite continued revenue challenges. The company achieved positive adjusted EBITDA of $2.9 million for the first time in eight quarters, alongside positive cash flow generation. The dramatic gross margin expansion to 42.9% (970 basis point improvement) reflects successful operational restructuring and cost-cutting initiatives.

Despite these improvements, the 11.6% revenue decline to $129 million highlights persistent demand softness. The company's full-year performance shows similar patterns: improved profitability metrics with adjusted EBITDA of -$20.8 million (vs. -$54.7 million in 2023) despite 4.4% lower revenue.

The securing of an additional $19 million in term loan financing provides critical liquidity to support planned innovation and advertising investments. This expanded borrowing capacity, combined with the PIK interest option, gives Purple financial flexibility during its turnaround.

Most significantly, the announcement of a strategic alternatives review following "inbound expressions of interest" potentially signals acquisition interest. This process could culminate in a sale, merger, or other transaction that might benefit shareholders beyond the company's operational improvements.

Purple's 2025 guidance ($465-485 million revenue and $0-10 million adjusted EBITDA) projects continued sequential improvement but indicates a lengthy path to sustainable profitability. The expected Q1 EBITDA loss of $6-9 million confirms near-term challenges remain.

Purple's results demonstrate classic restructuring progress where profitability metrics improve before revenue recovery. The company's turnaround strategy focuses on margin enhancement and cost discipline while preparing for future growth. The 15% reduction in inventory shows effective working capital management, converting excess stock into cash while maintaining gross margin improvement.

The restructuring efforts initiated in Q3 2024 are yielding tangible benefits with operating expenses down 2.6% year-over-year despite increased advertising investments. Management's reference to "additional measures in 2025 beyond the 2024 restructuring plan" signals ongoing cost optimization rather than a completed turnaround.

The term loan amendment provides a important liquidity cushion for executing the "Path to Premium" strategy. This capital infusion, combined with the PIK interest feature, alleviates near-term cash constraints without immediately increasing debt service requirements.

The strategic alternatives review comes at a logical juncture - after demonstrating operational improvements but before completing the full turnaround. This timing potentially maximizes value by showing progress while offering acquirers the opportunity to benefit from further recovery. With Purple's current market cap under $76 million against nearly $488 million in revenue, the company's enterprise value appears modest if it can sustain profitability improvements.

Investors should monitor sequential quarterly progress in 2025, particularly the pace of EBITDA improvement and any updates on the strategic review process, which typically concludes within 3-6 months.

Returned to Positive Adjusted EBITDA and Cash Flow in Fourth Quarter
GAAP Gross Margin of 42.9% in Q4; Adjusted Gross Margin improved Over 810bps in Q4 Versus Last Year
Generated Incremental Liquidity with New $19.0 Million Term Loan Increase to Support Continued Investments in Innovation and Advertising

LEHI, Utah, March 13, 2025 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple" or the "Company"), a comfort innovation company known for creating the "World's First No Pressure™ Mattress," today announced results for the fourth quarter and full year ended December 31, 2024.

"Purple achieved a significant milestone in the fourth quarter, returning to positive Adjusted EBITDA for the first time in eight quarters and generating positive cash flow," said CEO Rob DeMartini. "This accomplishment reflects our team's disciplined execution, operational improvements, and strategic cost-saving initiatives throughout the year. Looking forward, we are confident the durability we structured into the business through recent cost saving initiatives and the support of the additional borrowings under our term loan will enable the continued execution of our Path to Premium strategy. We look forward to bringing new products to market from our robust innovation pipeline, including our Rejuvenate 2.0 launch in the second quarter, which we believe will build on our strong foundation and drive improved profitability."

Fourth Quarter 2024 Financial Results
Fourth quarter 2024 net revenue declined by 11.6% to $129.0 million, compared to $145.9 million in the fourth quarter of 2023, driven by continued industry softness, as well as cycling the 2023 launch of our new mattress lines.

Gross profit for the fourth quarter increased to $55.3 million, compared to $48.5 million in the prior-year period. GAAP gross margin improved significantly to 42.9%, an increase of 970 basis points. Adjusted gross margin, which excludes restructuring-related charges and launch costs in the prior year, expanded to 44.9%, an improvement of over 810 basis points year-over-year, driven by continued improvements from sourcing initiatives and profitable liquidation of inventories. The Company plans to continue its focus on driving cost savings, including through additional measures in 2025 beyond the 2024 restructuring plan.

Operating expenses for the fourth quarter were $63.0 million, down 2.6% from $64.7 million in Q4 2023. This improvement was driven by disciplined cost control and benefits of the Company's restructuring activities in the third quarter of 2024, offset partially by an increase in advertising investments.

Net loss attributable to Purple Innovation, Inc. for the fourth quarter was $(8.5) million, an improvement from $(18.3) million in the prior year.

Adjusted EBITDA for the fourth quarter was $2.9 million, a significant improvement compared to $(9.8) million last year, demonstrating the benefits of higher ticket sizes from the Company's premium sleep strategy and restructuring initiatives.

Full Year 2024 Financial Results
For the full year 2024, net revenue was $487.9 million, down 4.4% compared to $510.5 million in 2023. DTC net revenue was $283.7 million, a decrease of 4.4%, while wholesale net revenue was $204.2 million, a decrease of 4.5%, due primarily to increased industry softness and cycling the launch in 2023 of the Company's new mattress product lines.

Gross profit for the full year increased to $181.1 million, compared to $171.8 million last year. GAAP gross margin for the year improved to 37.1%, an increase of 350 basis points year-over-year. Adjusted gross margin grew to 40.3%, up 310 basis points compared to the prior year, as the Company benefited from production efficiencies and sourcing initiatives.

Full-year operating expenses declined 4.6% to $273.3 million, compared to $285.5 million in 2023, with the benefits of cost savings initiatives and lapping special committee costs from 2023 being partially offset by $20.0 million in restructuring, impairment and other related charges.

Full-year net loss attributable to Purple Innovation, Inc. was $(97.9) million, an improvement from $(120.8) million in the prior year.

Adjusted EBITDA for the full year improved significantly to $(20.8) million, compared to $(54.7) million in 2023, reflecting the Company's strategic focus on improving profitability.

Balance Sheet
Cash and cash equivalents were $29.0 million as of December 31, 2024, compared to $26.9 million as of December 31, 2023, and compared to $23.3 million as of September 30, 2024, with the improvement in EBITDA driving positive cash flow in the fourth quarter.

Inventories as of December 31, 2024 totaled $56.9 million, compared to $66.9 million at December 31, 2023, representing a decrease of 15.0%.

Term Loan Amendment
As part of its ongoing capital management strategy, Purple borrowed an additional $19.0 million pursuant to an amendment to its existing term loan, bringing the total principal commitment to $80.0 million. As with our existing Term loan the increased amount includes the ability to PIK our interest.

Mr. DeMartini added, "We are grateful to our lenders for their continued confidence in Purple and our strategy, as demonstrated by this increased financial commitment. The additional capital will support Purple's liquidity position as we continue to invest in innovation and advertising and execute on our Path to Premium strategy."

2025 Outlook
For 2025, the Company currently expects full year revenue to be in the range of $465 to $485 million and adjusted EBITDA in the range of flat to positive $10 million. The Company expects its quarterly revenue and adjusted EBITDA performance to improve sequentially as it progresses through the year.

For the first quarter, the Company plans total revenue to be in the range of $102 to $107 million, and adjusted EBITDA in the range of $(6) to $(9) million.

Review of Strategic Alternatives
In a separate news release today, Purple announced that its Board of Directors has formed a special committee of independent directors to evaluate strategic alternatives to maximize shareholder value. The review, which was initiated following inbound expressions of interest, may include, but is not limited to, consideration of a sale, merger, or other strategic or financial transaction. There can be no assurances as to the outcome or timing of the review, or whether any particular transaction may be pursued or consummated.

Conference Call and Webcast Information
Purple Innovation, Inc. will host a live conference call to discuss financial results today, March 13, 2025 at 4:30 p.m. Eastern Time.  To access the call dial 844-481-1976 (domestic) or 412-317-0642 (international). The call is also being webcast and can be accessed on the investor relations section of the Company's website, investors.purple.com. After the conference call, a webcast replay will remain available on the investor relations section of the Company's website for 30 days.

About Purple
Purple, the leading premium mattress company with the #1 Gel Grid technology in the world, the GelFlex® Grid, thoughtfully engineers products that make restorative sleep effortless for every kind of sleeper. The result of over 30 years of innovation and in comfort technologies, Purple's GelFlex Grid is the most significant advancement in mattresses in decades and is proven to reduce aches and pains. It instantly adapts as you move, balances temperature, relieves pressure and offers support in all the right places. Purple products, including mattresses, pillows, cushions, frames, sheets, and more, can be found online at Purple.com, in 58 Purple stores and over 3,000 retailers nationwide. Sleep Better. Live Purple.

Forward Looking Statements
Certain statements made in this release that are not historical facts are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Statements based on historical data are not intended and should not be understood to indicate the Company's expectations regarding future events. Forward-looking statements provide current expectations or forecasts of future events or determinations. These statements include, but are not limited to, statements regarding the durability of our business, our execution of our Path to Premium strategy, our innovation pipeline, the timing of new product collection launches, our ability to improve profitability, our review of strategic alternatives and the timing and future prospects thereof. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Factors that could influence the realization of forward-looking statements include, among others: changes in economic, financial and end-market conditions in the markets in which we operate; fluctuations in raw material prices and cost of labor; the financial condition of our customers and suppliers; competitive pressures, including the need for technology improvement, successful new product development and introduction; changes in consumer demand, including pullbacks in consumer spending; disruptions to our manufacturing processes; and the risk factors outlined in the "Risk Factors" section of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 12, 2024, and in our other filings made with the SEC. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Non-GAAP Financial Measures
EBITDA, adjusted gross margin, adjusted EBITDA, adjusted net income, and adjusted net income per diluted share are non-GAAP financial measures that remove the impact of certain non-cash and non-recurring costs. Management believes that the use of such non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. Refer to the attached table for the reconciliation of such non-GAAP financial measures to the most comparable GAAP financial measure.

With respect to the Company's Adjusted EBITDA outlook for the full year 2025, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including but not limited to warrant liabilities and stock based compensation. For the same reasons, the Company is unable to assess the probable significance of the unavailable information, which could have a material impact on its future GAAP financial results.

Investor Contact:
Stacy Turnof, Edelman Smithfield
stacy.turnof@edelmansmithfield.com
917-362-2581

 

PURPLE INNOVATION, INC.

Condensed Consolidated Balance Sheets

(unaudited - in thousands, except par value)




December 31,



2024



2023

Assets






Current assets:






      Cash and cash equivalents


$

29,011



$

26,857

      Accounts receivable, net



33,057




37,802

      Inventories



56,863




66,878

      Prepaid expenses



6,023




8,536

      Other current assets



1,414




1,737

Total current assets



126,368




141,810

Property and equipment, net



93,874




128,661

Operating lease right-of-use assets



75,516




95,767

Intangible assets, net



8,890




22,196

Other long-term assets



3,197




2,191

Total assets


$

307,845



$

390,625









Liabilities and Stockholders' Equity








Current liabilities:








      Accounts payable


$

40,639



$

49,831

      Accrued compensation



9,415




5,064

      Customer prepayments



6,411




5,718

      Accrued rebates and allowances



10,013




13,243

      Accrued warranty liabilities – current portion



6,114




9,793

      Operating lease obligations – current portion



15,661




14,843

      Other current liabilities



12,750




12,490

Total current liabilities



101,003




110,982

Related party debt



55,394




Long-term debt, net of current portion






26,909

Accrued warranty liabilities, net of current portion



26,091




25,798

Operating lease obligations, net of current portion



87,072




109,094

Warrant liabilities



16,067




Other long-term liabilities



2,009




2,235

Total liabilities



287,636




275,018

Commitments and contingencies (Note 15)








Stockholders' equity:








      Class A common stock; $0.0001 par value, 210,000 shares authorized; 107,545 and

       105,507 issued and outstanding at December 31, 2024 and 2023, respectively



11




11

      Class B common stock; $0.0001 par value, 90,000 shares authorized; 165 and 205

       issued and outstanding at December 31, 2024 and 2023, respectively






      Additional paid-in capital



594,053




591,380

      Accumulated deficit



(573,866)




(475,969)

Total stockholders' equity attributable to Purple Innovation, Inc.



20,198




115,422

      Noncontrolling interest



11




185

Total stockholders' equity



20,209




115,607

Total liabilities and stockholders' equity


$

307,845



$

390,625

 

PURPLE INNOVATION, INC.

Condensed Consolidated Statements of Income

(unaudited - in thousands, except per share amounts)




Three Months Ended
December 31,



Year Ended
December 31,



2024



2023



2024



2023













Revenues, net


$

128,975



$

145,936



$

487,877



$

510,541

Cost of revenues:
















Cost of revenues



71,113




97,472




291,303




338,716

Cost of revenues – restructuring related charges



2,583







15,442




Total cost of revenues



73,696




97,472




306,745




338,716

Gross profit



55,279




48,464




181,132




171,825

Operating expenses:
















Marketing and sales



45,485




44,945




171,263




182,313

General and administrative



14,006




16,818




69,117




84,446

Research and development



2,390




2,897




12,962




11,898

Restructuring, impairment and other related charges



1,092







19,973




Loss on impairment of goodwill












6,879

Total operating expenses



62,973




64,660




273,315




285,536

Operating loss



(7,694)




(16,196)




(92,183)




(113,711)

Other (expense) income:
















Interest expense



(4,481)




(819)




(17,510)




(1,967)

Other (expense) income, net



(64)




(1,513)




11,548




(1,198)

Loss on extinguishment of debt









(3,394)




(4,331)

Change in fair value – warrant liabilities



3,615







3,504




Total other (expense) income, net



(930)




(2,332)




(5,852)




(7,496)

Net (loss) income before income taxes



(8,624)




(18,528)




(98,035)




(121,207)

Income tax (benefit) expense



(113)




(154)




63




8

Net loss



(8,511)




(18,374)




(98,098)




(121,215)

Net loss attributable to noncontrolling interest



(32)




(41)




(201)




(458)

Net loss attributable to Purple Innovation, Inc.


$

(8,479)



$

(18,333)



$

(97,897)



$

(120,757)

















Net loss per share:
















Basic


$

(0.08)



$

(0.17)



$

(0.91)



$

(1.17)

Diluted


$

(0.08)



$

(0.17)



$

(0.91)



$

(1.17)

















Weighted average common shares outstanding:
















Basic



107,528




105,503




107,139




103,602

Diluted



107,710




105,737




107,324




103,936

 

PURPLE INNOVATION, INC.

Condensed Consolidated Statements of Cash Flows

(unaudited - in thousands)




Three Months Ended
December 31,



Year Ended

December 31,



2024



2023



2024



2023

















Cash flows from operating activities:
















Net loss


$

(8,511)



$

(18,374)



$

(98,098)



$

(121,215)

Adjustments to reconcile net income (loss) to net cash provided by

(used in) operating activities:
















Depreciation and amortization



7,907




6,143




35,355




25,106

Non-cash interest



1,926




317




7,229




1,237

Paid-in-kind interest



2,651







9,679




Non-cash restructuring, impairment and other related charges



123








20,238




Loss on impairment of goodwill












6,879

Loss on extinguishment of debt









3,394




4,331

Loss on disposal of property and equipment






1,680




770




1,680

Change in fair value - warrant liabilities



(3,615)







(3,504)




Stock-based compensation



707




1,083




2,815




4,875

Changes in operating assets and liabilities:
















Accounts receivable



(3,395)




(5,116)




4,745




(3,651)

Inventories



3,018




5,207




5,989




5,903

Prepaid expenses and other assets



1,967




2,778




2,345




1,574

Operating leases, net



(307)




(58)




(2,412)




1,404

Accounts payable



10,182




3,838




(6,376)




4,382

Accrued Compensation



(5,694)




(826)




4,351




(1,627)

Customer prepayments



2,633




543




693




1,266

Accrued rebates and allowances



(27)




4,668




(3,230)




3,439

Accrued warranty liabilities



(2,765)




3,705




(3,386)




11,128

Other accrued liabilities



(39)




(4,442)




1,553




(1,373)

Net cash provided by (used in) operating activities



6,761




1,146




(17,850)




(54,662)

















Cash flows from investing activities:
















Excess restricted cash returned to acquiree












(826)

Purchase of property and equipment



(1,084)




(5,622)




(7,244)




(14,391)

Investment in intangible assets



(65)




(256)




(286)




(844)

Net cash used in investing activities



(1,149)




(5,878)




(7,530)




(16,061)

















Cash flows from financing activities:
















Proceeds from term loan












25,000

Proceeds revolving line of credit






17,000







17,000

Proceeds from related party loan











61,000




Payments on term loan









(25,000)




(24,656)

Payments on revolving line of credit






(12,000)




(5,000)




(12,000)

Proceeds from stock offering












60,300

Payments for stock offering costs












(3,301)

Proceeds from exercise of stock options












Payments for debt issuance costs






(17)




(3,466)




(6,143)

Proportional Representation Preferred Linked Stock redemption fee












(105)

Tax receivable agreement payments












(269)

Net cash provided by (used in) financing activities






4,983




27,534




55,826

















Net (decrease) increase in cash



5,612




251




2,154




(14,897)

Cash, beginning of the period



23,399




26,606




26,857




41,754

Cash, end of the period


$

29,011



$

26,857



$

29,011



$

26,857

 

PURPLE INNOVATION, INC.
RECONCILIATION OF GAAP TO NON-GAAP MEASURES
(In thousands)

Management believes that the use of the following non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. These non-GAAP financial measures are EBITDA, adjusted EBITDA, adjusted net loss, and adjusted net loss per diluted share. Other companies may calculate these non-GAAP measures differently than we do. These non-GAAP measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for our financial results prepared in accordance with GAAP.

Reconciliation of GAAP Net Loss to Non-GAAP EBITDA and Adjusted EBITDA

A reconciliation of GAAP net loss to the non-GAAP measures of EBITDA and adjusted EBITDA is provided below. EBITDA represents net loss before interest expense, income tax (benefit) expense, other expense (income), net, and depreciation and amortization. Adjusted EBITDA represents EBITDA excluding costs incurred due to changes in the fair value of the warrant liability, debt extinguishment, stock-based compensation expense, restructuring related charges, vendor separation fee, loss on project write-off, impairment of goodwill, nonrecurring legal fees, Board special committee costs, acquisition expenses, executive interim and search costs, severance costs and showroom opening and closing costs. We believe EBITDA and Adjusted EBITDA provide additional useful information with respect to the impact of various adjustments and provide meaningful measures of our operating performance.



Three Months Ended

 December 31,



Year Ended

December 31,



2024



2023



2024



2023













GAAP net loss


$

(8,511)



$

(18,374)



$

(98,098)



$

(121,215)

Interest expense



4,481




819




17,510




1,967

Income tax (benefit) expense



(113)




(154)




63




8

Other expense (income), net



64




1,513




(11,548)




1,198

Depreciation and amortization



7,907




6,143




35,355




25,106

EBITDA



3,828




(10,053)




(56,718)




(92,936)

Adjustments:
















Change in fair value - warrant liability



(3,615)







(3,504)




Loss on extinguishment of debt









3,394




4,331

Stock-based compensation expense



685




1,083




2,793




4,875

Restructuring related charges



1,378







25,047




Vendor separation fee












1,050

Loss on project write-off









1,355




Loss on impairment of goodwill












6,879

Legal fees



42




177




982




3,697

Board special committee fees






(2,750)







11,410

Acquisition expenses












65

Executive interim and search costs



233




1,117




3,616




4,375

Severance costs



146




282




1,232




868

Showroom opening/closing costs



174




353




956




691

Adjusted EBITDA


$

2,871



$

(9,791)



$

(20,847)



$

(54,695)

 

Reconciliation of GAAP Gross Profit to Adjusted Gross Profit 

A reconciliation of GAAP gross profit to the non-GAAP measures of adjusted gross profit is provided below. Adjusted gross profit represents adjusted net revenue less adjusted cost of revenue. Adjusted net revenue represents revenue adjusted for revenue deemed lost through discounts on products during our transition to our new product line in 2023. Adjusted cost of revenues represents cost of revenues excluding certain incremental costs incurred during our transition to our new product line in 2023 and restructuring charges recorded in cost of revenues in 2024. We believe adjusted gross margin provides additional useful information with respect to the impact of the new product launch and restructuring and provides meaningful measures of our operating performance.

(in thousands)


Three Months Ended
December 31,



 Year Ended
December 31,



2024



2023



2024



2023

   Revenues, net


$

128,975



$

145,936



$

487,877



$

510,541

   Discounts on new product transition






2,106







14,859

   Adjusted revenues, net



128,975




148,042




487,877




525,400

















Total cost of revenues



73,696




97,472




306,745




338,716

Cost of new product transition






(3,807)







(8,822)

Restructuring charges in cost of revenues



(2,583)







(15,442)




Adjusted cost of revenues



71,113




93,665




291,303




329,894

















Adjusted gross profit


$

57,862



$

54,377



$

196,574



$

195,506

Adjusted gross profit %



44.9 %




36.7 %




40.3 %




37.2 %

 

Reconciliation of GAAP Operating Expenses to Adjusted Operating Expenses 

A reconciliation of GAAP operating expenses to the non-GAAP measures of adjusted operating expenses is provided below. Adjusted operating expenses represents operating expenses adjusted for restructuring related charges in 2024 and the Board special committee fees and impairment of goodwill in 2023. We believe adjusted operating expenses provides additional useful information with respect to the impact of the restructuring and provides meaningful measures of our operating performance.

(in thousands)


Three Months Ended
December 31,



 Year Ended
December 31,



2024



2023



2024



2023

Operating expenses


$

62,973



$

64,660



$

273,315



$

285,536

Restructuring related charges in operating expenses



(1,092)







(20,915)




Board special committee fees






2,750







(11,410)

Loss on impairment of goodwill












(6,879)

Adjusted operating expenses


$

61,881



$

67,410



$

252,400



$

267,247

 

Reconciliation of GAAP Net Loss to non-GAAP Adjusted Net Loss and Adjusted Net Loss per Diluted Share

Our presentation of adjusted net loss assumes that all net loss is attributable to Purple Innovation, Inc. (i.e. there is no allocation of net loss to noncontrolling interests), which assumes the full exchange at the beginning of the period of all outstanding Paired Securities for shares of Class A common stock of Purple Innovation, Inc., adjusted for certain nonrecurring items that we do not believe directly reflect our core operations. Adjusted net loss per share, diluted, is calculated by dividing adjusted net loss by the total shares of Class A common stock outstanding plus any dilutive warrants, options and restricted stock as calculated in accordance with GAAP and assuming the full exchange of all outstanding Paired Securities as of the beginning of each period presented. Adjusted net loss and adjusted net loss per diluted share, are supplemental measures of operating performance that do not represent, and should not be considered, alternatives to net loss and loss per share, as calculated in accordance with GAAP. We believe adjusted net loss and adjusted net loss per diluted share, supplement GAAP measures and enable us to more effectively evaluate our performance period-over-period. A reconciliation of net loss, the most directly comparable GAAP measure, to adjusted net loss and the computation of adjusted net loss per diluted share, are set forth below:

(in thousands, except per share amounts)


Three Months Ended
December 31,



Year Ended

December 31,




2024




2023




2024




2023

















Net loss


$

(8,511)



$

(18,374)



$

(98,098)



$

(121,215)

Income tax (benefit) expense, as reported



(113)




(154)




63




8

Change in fair value – warrant liabilities



(3,615)







(3,504)




Loss on extinguishment of debt









3,394




4,331

Restructuring related charges



1,378







25,047




Loss on project write-off/vendor separation fee









1,355




1,050

Loss on impairment of goodwill












6,879

Board special committee fees






(2,750)







11,410

Acquisition expenses












65

Gain on insurance proceeds









(11,499)




Adjusted net loss before income taxes



(10,861)




(21,278)




(83,242)




(97,472)

Adjusted income tax benefit(1)



2,813




5,511




21,560




25,245

Adjusted net loss


$

(8,048)



$

(15,767)



$

(61,682)



$

(72,227)

















Adjusted net loss per share, diluted


$

(0.07)



$

(0.15)



$

(0.57)



$

(0.69)

















Adjusted weighted-average shares outstanding, diluted(2)



107,710




105,737




107,324




103,936


(1) Represents the estimated effective tax rate of 25.9% for the three months and year ended December 31, 2024 and 2023, applied to adjusted net income before income taxes. The estimated effective tax rates are what the Company would be subject to and consist of the combined federal statutory tax rate and the Company's blended state tax rates assuming no valuation allowance.


(2) Assumes options and restricted stock units calculated in accordance with GAAP and the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period.

 

A reconciliation of net income (loss) per share, diluted, to adjusted net income per diluted share is set forth below for the three months and year ended December 31, 2023 and 2022:



For the Three Months Ended



December 31, 2024



December 31, 2023



Net Loss



Weighted
Average
 Shares,
 Diluted



Net Loss
per
Share,
Diluted



Net Loss



Weighted
Average
Shares,
Diluted



Net Loss
per Share,
Diluted

























Net loss attributable to Purple Innovation Inc.(1)


$

(8,479)




107,710



$

(0.08)



$

(18,333)




105,737



$

(0.17)

    Assumed exchange of shares(2)



(32)












(41)









    Net loss



(8,511)












(18,374)









Adjustments to arrive at adjusted net loss before taxes(3)



(2,350)












(2,904)









    Adjusted net loss before taxes



(10,861)












(21,278)









    Adjusted income tax benefit(4)



2,813












5,511









    Adjusted net loss


$

(8,048)




107,710



$

(0.07)



$

(15,767)




105,737



$

(0.15)


(1) Represents net income attributable to Purple Innovation, Inc. and the associated weighted average diluted shares, of Class A common stock outstanding.


(2) Assumes the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period and added in if not already included in the weighted average diluted shares. Also assumes the addition of net income attributable to noncontrolling interests corresponding with the assumed exchange of the Paired Securities for shares of Class A common stock.


(3) Represents the total impact of all adjustments identified in the adjusted net income table above to arrive at adjusted income before income taxes. Also assumes the dilutive warrants, options and restricted stock as calculated in accordance with GAAP.


(4) Represents the estimated effective tax rate of 25.9% for the three months ended December 31, 2024 and 2023, applied to adjusted net income before income taxes. The estimated effective tax rates are what the Company would be subject to and consist of the combined federal statutory tax rate and the Company's blended state tax rates assuming no valuation allowance.

 



For the Year Ended



December 31, 2024



December 31, 2023



Net Loss



Weighted
Average
 Shares,
 Diluted



Net Loss
per
Share,
Diluted



Net Loss



Weighted
Average
Shares,
Diluted



Net Loss
per Share,
Diluted

























Net loss attributable to Purple Innovation Inc.(1)


$

(97,897)




107,324



$

(0.91)



$

(120,757)




103,936



$

(1.17)

   Assumed exchange of shares(2)



(201)












(458)









   Net loss



(98,098)












(121,215)









   Adjustments to arrive at adjusted net loss before taxes(3)



14,856












23,743









   Adjusted net loss before taxes



(83,242)












(97,472)









   Adjusted income tax benefit(4)



21,560












25,245









   Adjusted net loss


$

(61,682)




107,324



$

(0.57)



$

(72,227)




103,936



$

(0.69)


(1) Represents net income attributable to Purple Innovation, Inc. and the associated weighted average diluted shares, of Class A common stock outstanding.


(2) Assumes the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period and added in if not already included in the weighted average diluted shares. Also assumes the addition of net income attributable to noncontrolling interests corresponding with the assumed exchange of the Paired Securities for shares of Class A common stock.


(3) Represents the total impact of all adjustments identified in the adjusted net income table above to arrive at adjusted income before income taxes. Also assumes the dilutive warrants, options and restricted stock as calculated in accordance with GAAP.


(4) Represents the estimated effective tax rate of 25.9% the year ended December 31, 2024 and 2023, applied to adjusted net income before income taxes. The estimated effective tax rates are what the Company would be subject to and consist of the combined federal statutory tax rate and the Company's blended state tax rates assuming no valuation allowance.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/purple-innovation-reports-fourth-quarter-and-full-year-2024-results-302401465.html

SOURCE Purple Innovation, LLC

FAQ

What were Purple's (PRPL) Q4 2024 financial results?

Q4 revenue was $129.0M (-11.6% YoY), with gross margin of 42.9% and positive Adjusted EBITDA of $2.9M, marking first profitable quarter in 8 quarters.

What is Purple's (PRPL) revenue guidance for 2025?

Purple expects 2025 revenue between $465-485M with adjusted EBITDA ranging from flat to positive $10M.

How much additional term loan financing did Purple (PRPL) secure in 2024?

Purple secured an additional $19.0M term loan increase, bringing total principal commitment to $80.0M.

What strategic alternatives is Purple (PRPL) considering in 2025?

Purple formed a special committee to evaluate strategic alternatives including potential sale, merger, or other strategic transactions.

How did Purple's (PRPL) inventory levels change in 2024?

Inventory decreased 15% to $56.9M as of December 31, 2024, compared to $66.9M in 2023.
Purple Innovatio

NASDAQ:PRPL

PRPL Rankings

PRPL Latest News

PRPL Stock Data

72.37M
102.79M
4.41%
71.46%
3.24%
Furnishings, Fixtures & Appliances
Household Furniture
Link
United States
LEHI